Hemic and Lymphatic Diseases: News and Research on Coagulation Protein Disorders

MeSH tree: C15.378.100.141

FDA approves Hympavzi for hemophilia

The U.S. Food and Drug Administration (FDA) approved Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients aged 12 years and older with ...

Prenatal stem cells treat hemophilia A in preclinical study

Researchers at the Wake Forest Institute for Regenerative Medicine (WFIRM) have recently published an article in Nature Communications that demonstrates the potential of bioengineered human placental cells as a cure for Hemophilia ...

page 2 from 3